<DOC>
	<DOCNO>NCT01529476</DOCNO>
	<brief_summary>1 . This study test safety efficacy TG-873870 ( Nemonoxacin ) compare Levofloxacin adult patient Community-Aquired Pneumonia ( CAP ) 2 . To investigate population pharmacokinetics ( PPK ) nemonoxacin adult patient CAP continuous oral administration determine pharmacokinetic ( PK ) /pharmacodynamic ( PD ) .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Oral Administration With Nemonoxacin Levofloxacin Patients With CAP</brief_title>
	<detailed_description>Community-acquired Pneumonia ( CAP ) remain leading cause death develop developed country . In choice antibacterial agent use treat CAP , fluoroquinolones receive considerable attention wide spectrum bactericidal activity . TG-873870 ( Nemonoxacin ) , non-fluorinated quinolone ( NFQ ) , selective bacterial topoisomerase inhibitor . This study test safety efficacy TG-873870 ( Nemonoxacin ) compare Levofloxacin adult patient Community-Aquired Pneumonia ( CAP ) . Besides , population pharmacokinetics ( PPK ) nemonoxacin adult patient CAP continuous oral administration determine pharmacokinetic ( PK ) /pharmacodynamic ( PD ) .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>1 . Ages 18 70 ; 2 . Weighs 40 ~ 100 kg , BMI â‰¥ 18 kg/m2 ; 3 . Must clinical diagnosis CAP 4 . Chest Xray show new persist/progressive infiltrates 5 . If female , nonlactating risk pregnancy ( postmenopausal must use adequate birth control ) 6 . The patient able take drug orally . 1 . Patients CAP , investigator 's judgment , severe enough require hospitalization intravenous antibiotic therapy and/or supplemental oxygen therapy ICU support 2 . Known suspect severe bronchiectasis , cystic fibrosis , active pulmonary tuberculosis infection mycobacteria fungi , know bronchial obstruction , history postobstructive pneumonia , confound respiratory disease , lung cancer , malignancy metastatic lung , lung abscess , empyema , suspect aspiration pneumonia due vomiting , nonbacterial respiratory infection ( chronic obstructive pulmonary disease [ COPD ] exclusionary ) 3 . Clinically significant conduction abnormality 12lead ECG , QTc interval 4 . Potassium &lt; 3.5 mmol/L 5 . Any known disease seriously affect immune system 6 . Active hepatitis decompensated cirrhosis ; 7 . Have use quinolones fluoroquinolones within 14 day enrollment 8 . Patients longterm medication steroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Ofloxacin</keyword>
	<keyword>Levofloxacin</keyword>
	<keyword>Ofloxacin hydrochloride</keyword>
</DOC>